Veraxa Biotech AG - Post de-SPAC income statement data for the quarter ended Dec 2025. This income statement covers 2 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2024 | Dec2025 |
|---|---|---|
| Additional items | ||
| Shares Outstanding | 14.05M | 14.47M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 14.05M | 14.47M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 14.05M | 14.47M |
Pull Veraxa Biotech AG - Post de-SPAC's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=VRXA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "VRXA", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=VRXA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();